Instituto Dante Pazzanese de Cardiologia
São Paulo, 04012-909, Brazil
NCT Number: NCT02263482
Heart failure is a clinical syndrome that is the common end of several cardiac diseases with symptoms such as muscle fatigue, dyspnea and reduction of quality of life. To improve respiratory and general functional capacity of these patients, there are strategies that can be used such as inspiratory muscle training and peripheral muscle training (dynamic resistance training).
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
São Paulo, 04012-909, Brazil
After agreement with the written informed consent, 35 subjects with severe heart failure were included in this study. They were randomized in three groups: controls, low-intensity and moderate-intensity group. All volunteers were assessed at Baseline and 8-weeks intervention. Cardiac events were registered following two years from baseline. The present study aimed to assess the effects of a combined program of inspiratory and peripheral muscle training on respiratory and general functional capacity and quality of life in patients with chronic heart failure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention during the 8-weeks period of the study because of awaiting evaluation for cardiac rehabilitation or transplantation
Patients will be submitted to a 8-weeks training program with inspiratory muscle trained at 30% of the maximal inspiratory pressure (30 minutes/session/7 days/week) + peripheral muscle trained with exercises of upper limbs and lower limbs (50% 1 RM, increased every 2-weeks).
Patients will be submited to a 8 weeks training program, with inspiratory muscle trained at 15% of the maximal inspiratory pressure (30 minutes/session/7 days/week) + peripheral muscle trained with exercises of upper limbs and lower limbs (0,5 kg each)
Time frame: Before and after 8-weeks
Inspiratory and expiratory muscle strength was assessed by using a pressure transducer (MVD-300 Microhard System, GlobalMed, Porto Alegre, Brazil).
Time frame: Before and after 8-weeks
To assess functional capacity using walking distance (6-min walk test accordingly to ATS and ERS guidelines)
Time frame: Before and after 8-weeks
Pulmonary function will be assessed by spirometry.
Time frame: Before and after 8-weeks
1RM
Time frame: Before and after 8-weeks
MMP2, myoglobin, p-selectin, MPO, NGAL, sVCAM, IL-2, IL-3, IL-4, IL-8,MIP1-alpha, 17, VEGF by Multiplex analysis. Inflammatory cells in nasal lavage will be also investigated.
Time frame: Before and after 8-weeks
HRV is obtained from the spectral analysis of R-R intervals obtained from a heart rate monitor (Polar, S810, Kempele, Finland)
Time frame: Before and after 8-weeks
by a 24-hours holter system for continuous recording of ambulatory electrocardiographic signs
Time frame: Before and after 8-weeks
Patients will be classified as sedentary, irregularly active, active or verry active according to Matsudo's classification (2001).
Time frame: Before and after 8-weeks
by Short Form-36 and by Minnesota Living with Heart Failure Questionnaire
Time frame: Before and after 8-weeks
A blood sample of 5 ml will be collected in a tube and BNP measured
Naomi Kondo Nakagawa
Other
Inspiratory Muscle and Peripheral Muscle Combined Training Effects on the Respiratory and Functional Capacity and Quality of Life in Chronic Heart Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07697365
Cardiovascular Diseases, Chronic Heart Failure
Athens, Attica, Greece
View Trial DetailsNCT07599345
Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction
Boston, Massachusetts, United States
View Trial DetailsNCT07599293
Chronic Heart Failure, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT06299826
Chronic Heart Failure
Alexander City, Alabama, United States
View Trial Details